Search

Your search keyword '"Nichols, Erin"' showing total 196 results

Search Constraints

Start Over You searched for: Author "Nichols, Erin" Remove constraint Author: "Nichols, Erin"
196 results on '"Nichols, Erin"'

Search Results

5. "It's like Lifting the Power": Powerlifting, Digital Gendered Subjectivities, and the Politics of Multiplicity.

7. A phase I study of the PD-L1 inhibitor, durvalumab, in combination with a PARP inhibitor, olaparib, and a VEGFR1–3 inhibitor, cediranib, in recurrent women’s cancers with biomarker analyses

8. Can verbal autopsies be used on a national scale? Key findings and lessons from South Africa's national cause-of-death validation study.

9. Supplementary Data from Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study

11. Mortality surveillance during the COVID-19 pandemic

15. Can verbal autopsies be used on a national scale? Key findings and lessons from the South Africa National Cause-of-Death Validation Study.

16. Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations

17. Mixed-methods analysis of select issues reported in the 2016 World Health Organization verbal autopsy questionnaire

18. Evaluation of approaches to strengthen civil registration and vital statistics systems: A systematic review and synthesis of policies in 25 countries

19. Improving mortality data in Jordan: a 10 year review/Ameliorer les donnees de mortalite en Jordanie: analyse decennale/Mejora de los datos sobre mortalidad en Jordania: analisis de los ultimos 10 anos

21. Estimating causes of death where there is no medical certification: evolution and state of the art of verbal autopsy

23. Risk factors for Ebola virus disease among household care providers, Sierra Leone, 2015.

24. The WHO 2016 verbal autopsy instrument: An international standard suitable for automated analysis by InterVA, InSilicoVA, and Tariff 2.0

25. Psychological distress in Australian psychology undergraduates: Exploring the role of self-care, dispositional mindfulness, and autonomous functioning

29. Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study

31. "I Would Report It Even If They Have Not Committed Anything": Social Service Students' Attitudes Toward Minor-Attracted People.

32. Additional file 5: of A phase I study of the PD-L1 inhibitor, durvalumab, in combination with a PARP inhibitor, olaparib, and a VEGFR1â 3 inhibitor, cediranib, in recurrent womenâ s cancers with biomarker analyses

33. Additional file 2: of A phase I study of the PD-L1 inhibitor, durvalumab, in combination with a PARP inhibitor, olaparib, and a VEGFR1–3 inhibitor, cediranib, in recurrent women’s cancers with biomarker analyses

34. Additional file 4: of A phase I study of the PD-L1 inhibitor, durvalumab, in combination with a PARP inhibitor, olaparib, and a VEGFR1–3 inhibitor, cediranib, in recurrent women’s cancers with biomarker analyses

35. Additional file 1: of A phase I study of the PD-L1 inhibitor, durvalumab, in combination with a PARP inhibitor, olaparib, and a VEGFR1–3 inhibitor, cediranib, in recurrent women’s cancers with biomarker analyses

36. Additional file 3: of A phase I study of the PD-L1 inhibitor, durvalumab, in combination with a PARP inhibitor, olaparib, and a VEGFR1â 3 inhibitor, cediranib, in recurrent womenâ s cancers with biomarker analyses

37. Phase I with expansion cohorts in a study of NEO-201 in adults with chemo-resistant solid tumors.

38. Phase 1 with expansion cohorts in a study of NEO-201 in adults with chemo-resistant solid tumors.

39. National health information systems for achieving the Sustainable Development Goals

40. Additional file 2: of Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations

44. Integrating community-based verbal autopsy into civil registration and vital statistics (CRVS) : system-level considerations

45. Interagency technical consultation on improving mortality reporting in Sierra Leone: meeting report

47. Integrating community-based verbal autopsy into civil registration and vital statistics (CRVS): system-level considerations

Catalog

Books, media, physical & digital resources